drugset / Trial / NCT03072485

Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers

NCT03072485

Phase 1 Completed 10 enrolled Anne Chang
Non-randomizedSequentialDouble-blindBasic science

Summary

This is a phase 1 study in healthy adult volunteers to examine the effects of 3 FDA approved medications on skin aging when applied in topical form. This is an open label, placebo controlled study.

Timeline

Start
2017-03-01
Primary completion
2019-02-22
Completion
2019-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified Topical
Subject Metformin Small molecule Topical
Subject Sirolimus Small molecule Topical

Indications

No indication recorded.